Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells - PubMed (original) (raw)
. 1992 Jan 15;79(2):495-502.
Affiliations
- PMID: 1730093
Free article
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells
M Pettersson et al. Blood. 1992.
Free article
Abstract
The bcl-2 gene, encoding a mitochondrial membrane protein suggested to play an important role in cell survival, is translocated into the Ig loci in about 80% of human follicular lymphomas, which results in a high level of expression. This report shows that bcl-2 was expressed in eight of eight human multiple myeloma cell lines and in normal lymph node and bone marrow plasma cells. In the majority of the myeloma lines, the level of expression was comparable with that observed in Karpas 422, a follicular lymphoma cell line carrying a 14;18 translocation of the bcl-2 gene. DNA rearrangements of the bcl-2 locus were evident in only one of the myeloma cell lines, U-266-1970. In this cell line, which exhibited the highest bcl-2 expression, a fourfold increased copy number of the bcl-2 gene was estimated by Southern analysis. This amplification was lost in cells of later passages (U-266-1984), suggesting that bcl-2 might possibly have played a role in the tumor development in vivo. Our results are in contrast to previous observations in murine plasmacytoma, in which bcl-2 was shown to be silent. The results also contradict the published observation that bcl-2 is not expressed at terminal stages of B-cell differentiation. It is at present unclear whether the high expression of bcl-2 in human myeloma is the result of a deregulated expression associated with the malignant phenotype or a mere reflection of the bcl-2 expression typical of normal plasma cells.
Similar articles
- C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
Rasmussen T, Knudsen LM, Dahl IM, Johnsen HE. Rasmussen T, et al. Leuk Lymphoma. 2003 Oct;44(10):1761-6. doi: 10.1080/1042819031000111035. Leuk Lymphoma. 2003. PMID: 14692531 - BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A. Tu Y, et al. Cancer Res. 1998 Jan 15;58(2):256-62. Cancer Res. 1998. PMID: 9443402 - Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER, Piché L, Lemieux G, Lemieux R. Gauthier ER, et al. Cancer Res. 1996 Mar 15;56(6):1451-6. Cancer Res. 1996. PMID: 8640839 - BCL-6 protein is expressed in germinal-center B cells.
Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. Cattoretti G, et al. Blood. 1995 Jul 1;86(1):45-53. Blood. 1995. PMID: 7795255 - Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini B, Fizzotti M, Pileri S, Liso A, Pasqualucci L, Flenghi L. Falini B, et al. Ann Oncol. 1997;8 Suppl 2:101-4. Ann Oncol. 1997. PMID: 9209651 Review.
Cited by
- 8-Chloroadenosine 3',5'-monophosphate induces cell cycle arrest and apoptosis in multiple myeloma cells through multiple mechanisms.
Cheng YM, Zhu Q, Yao YY, Tang Y, Wang MM, Zou LF. Cheng YM, et al. Oncol Lett. 2012 Dec;4(6):1384-1388. doi: 10.3892/ol.2012.905. Epub 2012 Sep 11. Oncol Lett. 2012. PMID: 23226809 Free PMC article. - Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.
Amit-Vazina M, Shishodia S, Harris D, Van Q, Wang M, Weber D, Alexanian R, Talpaz M, Aggarwal BB, Estrov Z. Amit-Vazina M, et al. Br J Cancer. 2005 Jul 11;93(1):70-80. doi: 10.1038/sj.bjc.6602637. Br J Cancer. 2005. PMID: 15970928 Free PMC article. - Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones.
Distelhorst CW. Distelhorst CW. Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1795-1804. doi: 10.1016/j.bbamcr.2018.07.020. Epub 2018 Jul 25. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 30053503 Free PMC article. Review. - AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia.
Paulus A, Chitta K, Akhtar S, Personett D, Miller KC, Thompson KJ, Carr J, Kumar S, Roy V, Ansell SM, Mikhael JR, Dispenzieri A, Reeder CB, Rivera CE, Foran J, Chanan-Khan A. Paulus A, et al. Br J Haematol. 2014 Feb;164(3):352-365. doi: 10.1111/bjh.12633. Epub 2013 Nov 17. Br J Haematol. 2014. PMID: 24236538 Free PMC article. - Multiple myeloma: increasing evidence for a multistep transformation process.
Hallek M, Bergsagel PL, Anderson KC. Hallek M, et al. Blood. 1998 Jan 1;91(1):3-21. Blood. 1998. PMID: 9414264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical